[文献资料]参 考 文 献

The addition of rituximab to a combination of fludarabine，cyclophosphamide。Mitoxant rone（FCM）significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lym ......